Company intelligence / Profile preview

Sphere Labs

Cambridge, England, United Kingdomsphere-labs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sphere Bio is a commercial-stage provider of picodroplet-based microfluidic platforms for high-throughput single-cell analysis and isolation. Their technologies are widely used in biologics discovery, cell line development, cell engineering, and synthetic biology. The company has over 400 international customers, including seven of the world’s top ten pharmaceutical companies[1].

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Redbert Biotechnology (exclusive distribution partner in China)

Beyond the preview

Go deeper on Sphere Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sphere Labs.

Explore the full profile